ResearcherSun Yat-sen UniversityNo recent work listed
Man Li
Matched on ORCID iD 0000-0002-5710-5175; OpenAlex author ID A5108049291. Sources: OpenAlex.
Their work
- Papers
- 9
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: 2 papers · 2023: 1 paper
Papers 9
- Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy. Co-author DOI 10.1002/adma.202303736↗
- Spatially targeting and regulating tumor-associated macrophages using a raspberry-like micellar system sensitizes pancreatic cancer chemoimmunotherapy. Co-author DOI 10.1039/d2nr03053e↗
- Integrated Analysis of Glutathione Metabolic Pathway in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2022.896136↗
- Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles. Co-author DOI 10.1016/j.actbio.2021.05.002↗
- Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression. Co-author DOI 10.1016/j.ejpb.2021.05.014↗
- Comprehensively enhanced delivery cascade by transformable beaded nanofibrils for pancreatic cancer therapy. Co-author DOI 10.1039/d1nr02017j↗
- Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cancer progression and metastasis. Co-author DOI 10.7150/thno.60437↗
- Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therap… Co-author DOI 10.1016/j.jconrel.2020.02.011↗
- Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2019.05.019↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhirong Zhang · 6 shared papers, 2019–2021 · strength 0.69
- Paper Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immu… DOI 10.1016/j.ejpb.2021.05.014↗
- Paper Comprehensively enhanced delivery cascade by transformable beaded nanofibrils for pancreatic cancer therapy. DOI 10.1039/d1nr02017j↗
- Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
- Qin He · 5 shared papers, 2019–2021 · strength 0.56
- Paper Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immu… DOI 10.1016/j.ejpb.2021.05.014↗
- Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437↗
- Miao Deng · 3 shared papers, 2019–2023 · strength 0.41
- Paper Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy. DOI 10.1002/adma.202303736↗
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437↗
- Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019↗
- Jiao He · 2 shared papers, 2021–2023 · strength 0.32
- Paper Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy. DOI 10.1002/adma.202303736↗
- Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
- Ting Li · 2 shared papers, 2021–2022 · strength 0.27
- Qin Shu He · 2 shared papers, 2021–2022 · strength 0.27
- Qinglin Sheng · 2 shared papers, 2021 · strength 0.24
- Qianwen Yu · 2 shared papers, 2020–2021 · strength 0.22
- Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
- Paper Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated … DOI 10.1016/j.jconrel.2020.02.011↗
- Qin He · 1 shared paper, 2023 · strength 0.20
- Xiaoxiao Chen · 2 shared papers, 2019–2021 · strength 0.20
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437↗
- Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019↗
- Ji Liu · 1 shared paper, 2022 · strength 0.15
- Zhengze Lu · 1 shared paper, 2021 · strength 0.14
- Shuxia Zhang · 1 shared paper, 2022 · strength 0.13
- Fenjie Li · 1 shared paper, 2022 · strength 0.13
- Xingui Wu · 1 shared paper, 2022 · strength 0.13
- Jun Li · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.